California Nanotechnologies Corp. (CANOF)
Cerritos, CA, US
California Nanotechnologies Corp. specializes in the research, development, and manufacturing of nano-structured components and advanced materials. The company offers a comprehensive suite of services, encompassing advanced material processing techniques such as spark plasma sintering (SPS), cryogenic milling, and wire electrical discharge machining. They also perform various milling operations (planetary, ball, V-blending/tumble), undertake hot pressing tooling fabrication and design, and provide machining for metals and metallic alloys. Furthermore, their capabilities include material characterization via particle size analysis (using laser diffraction) and mechanical testing (tensile, compression, and hardness). In addition to services, their product portfolio includes SPS starter accessory kits, graphite and tungsten carbide tooling, graphite crucibles, and spark plasma sintering machines, alongside carbon graphite foil/paper, carbon felt, yarn, and quartz glass windows. Their diverse clientele spans critical sectors including microchip manufacturing, aerospace, defense, automotive, medical, oil and gas, and sports and recreation. The company's operations are based in Cerritos, California.
Based on only 1 article — low confidence
- California Nanotechnologies Announces Stock Options Newsfile Corp
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +7.68% | -13.49% | -2.97% | -15.47% | -21.00% | -23.46% | -54.76% | +47.19% | +156.50% | +207.64% | +397.01% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-54.5% Q1'26: -17.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-1,120.6% Q1'26: +107.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-45.3% Q1'26: +0.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-71.5% Q1'26: -41.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-65.9% Q1'26: -51.5% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+1.1% Q1'26: +5.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-0.99× Q1'26: -1.49× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Feb 2026 1 Rev. Ana. 1 EPS Ana. |
Feb 2027 1 Rev. Ana. 1 EPS Ana. |
Feb 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|
| Revenue |
2.70M
2.70M – 2.70M
|
2.21M
2.21M – 2.21M
-18.2% YoY
|
3.65M
3.65M – 3.65M
+65.0% YoY
|
| EBITDA |
612.5K
612.5K – 612.5K
|
501.0K
501.0K – 501.0K
-18.2% YoY
|
826.6K
826.6K – 826.6K
+65.0% YoY
|
| EBIT |
312.8K
312.8K – 312.8K
|
255.9K
255.9K – 255.9K
-18.2% YoY
|
422.1K
422.1K – 422.1K
+65.0% YoY
|
| Net Income |
-2.25M
-2.25M – -2.25M
|
-1.73M
-1.73M – -1.73M
+23.2% YoY
|
-865.5K
-865.5K – -865.5K
+50.0% YoY
|
| SGA |
985.6K
985.6K – 985.6K
|
806.2K
806.2K – 806.2K
-18.2% YoY
|
1.33M
1.33M – 1.33M
+65.0% YoY
|
| EPS |
-0.05
-0.05 – -0.05
|
-0.04
-0.04 – -0.04
+23.2% YoY
|
-0.02
-0.02 – -0.02
+50.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Eric Eyerman | Chief Executive Officer & Director | 485.4K | male |
| Christopher Trenton Melnyk | Chief Technology Officer | 267.3K | male |
| Roger Dent | Interim Chief Financial Officer & Director | 47.1K | male |
| Spencer Song | Vice President of Operations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CANOF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
